Vascular Solutions, Inc.  

(Public, NASDAQ:VASC)   Watch this stock  
Find more results for VASC
30.67
-0.41 (-1.32%)
Real-time:   1:00PM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 30.52 - 30.94
52 week 18.42 - 31.74
Open 30.94
Vol / Avg. 24,569.00/186,399.00
Mkt cap 529.54M
P/E 42.36
Div/yield     -
EPS 0.72
Shares 17.27M
Beta -0.02
Inst. own 66%
Apr 20, 2015
Q1 2015 Vascular Solutions Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Feb 3, 2015
Q4 2014 Vascular Solutions Inc Earnings Call
Feb 3, 2015
Q4 2014 Vascular Solutions Inc Earnings Release
Jan 8, 2015
Preliminary Q4 and Full Year 2014 Vascular Solutions Inc Revenue Results
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 12.39% 10.10%
Operating margin 15.82% 15.80%
EBITD margin - 19.69%
Return on average assets 13.32% 10.81%
Return on average equity 15.08% 12.15%
Employees 485 -
CDP Score - -

Address

6464 Sycamore Ct N
MAPLE GROVE, MN 55369-6032
United States - Map
+1-763-6564300 (Phone)
+1-877-6564251 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Vascular Solutions, Inc. (Vascular) is a medical device company focused on providing clinically advanced solutions to interventional cardiologists and interventional radiologists. Vascular offers product and service in three categories: catheter products, hemostat products and vein products and services. Catheter products consists of catheters used in minimally invasive medical procedures for the diagnosis or treatment of vascular conditions and also including products used in connection with gaining percutaneous access to the vasculature to perform minimally invasive procedures. Hemostat (blood clotting) products consist of the D-Stat Dry hemostat, a topical thrombin-based pad with a bandage used to control surface bleeding, and the D-Stat Flowable. Vein products consists of the Vari-Lase endovenous laser, a laser console and procedure kit used for the treatment of varicose veins.

Officers and directors

John L. Erb Independent Chairman of the Board
Age: 65
Bio & Compensation  - Reuters
Howard C Root Chief Executive Officer and Director
Age: 54
Bio & Compensation  - Reuters
James Hennen Chief Financial Officer, Senior Vice President - Finance, Corporate Secretary
Age: 42
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
William Rutstein Senior Vice President - Worldwide Sales
Age: 62
Bio & Compensation  - Reuters
Chad J. Kugler Senior Vice President of Research and Development
Age: 43
Bio & Compensation  - Reuters
Charmaine Sutton Senior Vice President - Operations
Age: 55
Bio & Compensation  - Reuters
Susan Christian Vice President - Sales Operations
Age: 45
Bio & Compensation  - Reuters
Carrie Powers Vice President - Marketing
Age: 40
Bio & Compensation  - Reuters
Phillip E. Nalbone Vice President - Corporate Development
Age: 52
Bio & Compensation  - Reuters
Brett Demchuk Vice President - Product Quality
Age: 49
Bio & Compensation  - Reuters